blog

Early-phase drug development is a complex process. Discover how Altasciences, as an integrated CRO/CDMO, alleviates the challenges and reduces risks.

Explore emerging areas of drugs from psychedelics and gene therapy, oligonucleotides to GLP-1RA for metabolic disorders.

Can the drug development industry change for the better? We dive into the obstacles and inefficiencies of the traditional outsourcing paradigm, and discuss how Altasciences offers an alternative to help sponsors safely accelerate their R&D.

Discover the inspiring journey of Altasciences’ Marta Rodriguez, Director of Clinical and Study Operations, who decided to pursue science after her parents fell ill.

Learn more about how Altasciences can test cognition, and the impact of driving under the influence of medication, using our state-of-the-art driving simulators.

Discover expert insights, tips, guidances and more resources, that you may have missed since our last recap